Misconceptions in acute heart failure diagnosis and Management in the Emergency Department



      Acute heart failure (AHF) accounts for a significant number of emergency department (ED) visits, and the disease may present along a spectrum with a variety of syndromes.


      This review evaluates several misconceptions concerning heart failure evaluation and management in the ED, followed by several pearls.


      AHF is a heterogeneous syndrome with a variety of presentations. Physicians often rely on natriuretic peptides, but the evidence behind their use is controversial, and these should not be used in isolation. Chest radiograph is often considered the most reliable imaging test, but bedside ultrasound (US) provides a more sensitive and specific evaluation for AHF. Diuretics are a foundation of AHF management, but in pulmonary edema, these medications should only be provided after vasodilator administration, such as nitroglycerin. Nitroglycerin administered in high doses for pulmonary edema is safe and effective in reducing the need for intensive care unit admission. Though classically dopamine is the first vasopressor utilized in patients with hypotensive cardiogenic shock, norepinephrine is associated with improved outcomes and lower mortality. Disposition is complex in patients with AHF, and risk stratification tools in conjunction with other assessments allow physicians to discharge patients safely with follow up.


      A variety of misconceptions surround the evaluation and management of heart failure including clinical assessment, natriuretic peptide use, chest radiograph and US use, nitroglycerin and diuretics, vasopressor choice, and disposition. This review evaluates these misconceptions while providing physicians with updates in evaluation and management of AHF.


      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Roger V.L.
        Epidemiology of heart failure.
        Circ Res. 2013; 113: 646-659
        • Bui A.L.
        • Horwich T.B.
        • Fonarow G.C.
        Epidemiology and risk profile of heart failure.
        Nat Rev Cardiol. 2011; 8: 30-41
        • Collins S.P.
        • Storrow A.B.
        Acute heart failure risk stratification: can we define low risk?.
        Heart Fail Clin. 2009; 5: 75-83
        • Go A.S.
        • Mozaffarian D.
        • Roger V.L.
        • Benjamin E.J.
        • Berry J.D.
        • Blaha M.J.
        • et al.
        Heart disease and stroke statistics—2014 update: a report from the American Heart Association.
        Circulation. 2014; 129: e28-292
        • Storrow A.B.
        • Jenkins C.A.
        • Self W.H.
        • et al.
        The burden of acute heart failure on U.S. emergency departments.
        JACC Heart Fail. 2014; 2: 269-277
        • Pang P.S.
        • Collins S.P.
        Acute heart failure in the emergency department: just a one night stand?.
        Acad Emerg Med. 2017; 24: 385-387
        • Pang P.S.
        • Collins S.P.
        • Miro O.
        • et al.
        The role of the emergency department in the management of acute heart failure: an international perspective on education and research.
        Eur Heart J Acute Cardiovasc Care. 2017; 6: 421-429
        • Silvers S.M.
        • Howell J.M.
        • Kosowsky J.M.
        • et al.
        Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes.
        Ann Emerg Med. 2007; 49: 627-669
        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • et al.
        ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/American heart association task force on practice guidelines.
        J Am Coll Cardiol. 2013; 62: 147-239
        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • et al.
        2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the Management of Heart Failure.
        JACC. 2017; 70: 776-803
        • Hunt S.A.
        • Abraham W.T.
        • Chin M.H.
        • et al.
        ACC/AHA 2005 guideline update for the diagnosis and Management of Chronic Heart Failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.
        Circulation. 2005; 112e154–e235
        • McMurray J.J.
        • Adamopoulos S.
        • Anker S.D.
        • et al.
        ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC.
        Eur Heart J. 2012; 33: 1787-1847
        • Haug C.
        • Metzele A.
        • Kochs M.
        • et al.
        Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure.
        Clin Cardiol. 1993; 16: 553-557
        • Darbar D.
        • Davidson N.C.
        • Gillespie N.
        • et al.
        Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction.
        Am J Cardiol. 1996; 78: 284-287
        • Omland T.
        • Aakvaag A.
        • Bonarjee V.V.S.
        • et al.
        Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
        Circulation. 1996; 93: 1963-1969
        • Valli N.
        • Gobinet A.
        • Bordenave L.
        Review of 10 years of the clinical use of brain natriuretic peptide in cardiology.
        J Lab Clin Med. 1999; 134: 437-444
        • Maeda K.
        • Tsutamoto T.
        • Wada A.
        • et al.
        High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality with congestive heart failure.
        J Am Coll Cardiol. 2000; 36: 1587-1593
        • Maisel A.S.
        • Krishnaswamy P.
        • Nowak R.M.
        • et al.
        Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
        N Engl J Med. 2002; 347: 161-167
        • McCullough P.A.
        • Nowak R.M.
        • McCord J.
        B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from breathing not properly (BNP) Multinational Study.
        Circulation. 2002; 106: 416-422
        • Maisel A.
        • Hollander J.E.
        • Guss D.
        Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
        J Am Coll Cardiol. 2004; 44: 1328-1333
        • Roberts E.
        • Ludman A.J.
        • Dworzynski K.
        The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting.
        BMJ. 2015; 350: h910
        • Martindale J.L.
        • Wakai A.
        • Collins S.P.
        Diagnosing acute heart failure in the emergency department: a systematic review and meta-analysis.
        Acad Emerg Med. 2016; 23: 223-242
        • Mueller C.
        • Scholer A.
        • Laule-Kilian K.
        Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.
        N Engl J Med. 2004; 350: 647-654
        • Moe G.W.
        • Howlett J.
        • Januzzi J.L.
        • Zowall H.
        N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study.
        Circulation. 2007; 115: 3103-3110
        • Rutten J.H.
        • Steyerberg E.W.
        • Boomsma F.
        N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
        Am Heart J. 2008; 156: 71-77
        • Schneider H.G.
        • Lam L.
        • Lokuge A.
        B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea: a randomized trial.
        Ann Intern Med. 2009; 150: 365-371
        • Singer A.J.
        • Birkhahn R.H.
        • Guss D.
        Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II): a randomized controlled trial of the effect of serial B-type natriuretic peptide testing on patient management.
        Circ Heart Fail. 2009; 2: 287-293
        • Boldanova T.
        • Noveanu M.
        • Breidthardt T.
        Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type natriuretic peptide for acute shortness of breath evaluation (BASEL) study.
        Int J Cardiol. 2010; 142: 265-272
        • Meisel S.R.
        • Januzzi J.L.
        • Medvedovski M.
        Pre-admission NT-proBNP improves diagnostic yield and risk stratification – the NT-proBNP for EValuation of dyspnoeic patients in the emergency room and hospital (BNP4EVER) study.
        Eur Heart J Acute Cardiovasc Care. 2012; 1: 99-108
        • Steinhart B.D.
        • Levy P.
        • Vandenberghe H.
        A randomized control trial using a validated prediction model for diagnosing acute heart failure in undifferentiated dyspneic emergency department patients-results of the GASP4Ar study.
        J Card Fail. 2017; 23: 145-152
        • Ray P.
        • Arthaud M.
        • Birolleau S.
        • et al.
        Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary edema in patients aged 65 and older.
        J Am Geriatr Soc. 2005; 53: 643-648
        • Mueller T.
        • Gegenhuber A.
        • Poelz W.
        • et al.
        Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
        Heart. 2005; 91: 606-612
        • Öhman J.
        • Harjola V.P.
        • Karjalainen P.
        • Lassus J.
        Rapid cardiothoracic ultrasound protocol for diagnosis of acute heart failure in the emergency department.
        Eur J Emerg Med. 2017 Oct 3; ([Epub ahead of print])
        • Russell F.M.
        • Ehrman R.R.
        A modified lung and cardiac ultrasound protocol saves time and rules in the diagnosis of acute heart failure.
        J Emerg Med. 2017 Jun; 52: 839-845
        • Jambrik Z.
        • Monti S.
        • Coppola V.
        • et al.
        Usefulness of ultrasound lung comets as a nonradiologic sign of extravascular lung water.
        Am J Cardiol. 2004; 93: 1265-1270
        • Mallamaci F.
        • Benedetto F.A.
        • Tripepi R.
        • et al.
        Detection of pulmonary congestion by chest ultrasound in dialysis patients.
        JACC Cardiovasc Imaging. 2010; 3: 586-594
        • Anderson K.L.
        • Fields J.M.
        • Panebianco N.L.
        • et al.
        Inter-rater reliability of quantifying pleural B-lines using multiple counting methods.
        J Ultrasound Med. 2013; 32: 115-120
        • Agricola E.
        • Bove T.
        • Oppizzi M.
        • et al.
        “Ultrasound comet-tail images”: a marker of pulmonary edema: a comparative study with wedge pressure and extravascular lung water.
        Chest. 2005; 127: 1690-1695
        • Anderson K.L.
        • Jenq K.Y.
        • Fields J.M.
        • et al.
        Diagnosing heart failure among acutely dyspneic patients with cardiac, inferior vena cava, and lung ultrasonography.
        Am J Emerg Med. 2013; 31: 1208-1214
        • Gil Martinez P.
        • Mesado Martinez D.
        • Curbelo Garcia J.
        • et al.
        Amino-terminal pro-B-type natriuretic peptide, inferior vena cava ultrasound, and bioelectrical impedance analysis for the diagnosis of acute decompensated CHF.
        Am J Emerg Med. 2016; 34: 1817-1822
        • Kajimoto K.
        • Madeen K.
        • Nakayama T.
        • et al.
        Rapid evaluation by lung-cardiac-inferior vena cava (LCI) integrated ultrasound for differentiating heart failure from pulmonary disease as the cause of acute dyspnea in the emergency setting.
        Cardiovasc Ultrasound. 2012; 10: 49
        • Miller J.B.
        • Sen A.
        • Strote S.R.
        • et al.
        Inferior vena cava assessment in the bedside diagnosis of acute heart failure.
        Am J Emerg Med. 2012; 30: 778
        • Silverstein J.R.
        • Laffely N.H.
        • Rifkin R.D.
        Quantitative estimation of left ventricular ejection fraction from mitral valve E-point to septal separation and comparison to magnetic resonance imaging.
        Am J Cardiol. 2006; 97: 137-140
        • Nazerian P.
        • Vanni S.
        • Zanobetti M.
        • et al.
        Diagnostic accuracy of emergency Doppler echocardiography for identification of acute left ventricular heart failure in patients with acute dyspnea: comparison with Boston criteria and N-terminal prohormone brain natriuretic peptide.
        Acad Emerg Med. 2010; 17: 18-26
        • Russell F.M.
        • Ehrman R.R.
        • Cosby K.
        • et al.
        Diagnosing acute heart failure in patients with undifferentiated dyspnea: a lung and cardiac ultrasound (LuCUS) protocol.
        Acad Emerg Med. 2015; 22: 182-191
        • Collins S.
        • Storrow A.B.
        • Kirk J.D.
        • et al.
        Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department.
        Ann Emerg Med. 2008; 51: 45-57
        • Cleland J.G.
        • Swedberg K.
        • Follath F.
        • et al.
        Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patients characteristics and diagnosis.
        Eur Heart J. 2003; 24: 442-463
        • Jessup M.
        • Abraham W.T.
        • Casey D.E.
        • et al.
        ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.
        J Am Coll Cardiol. 2009; 54: 1343-1382
        • Sica D.A.
        Pharmacotherapy in congestive heart failure: drug absorption in the management of congestive heart failure: loop diuretics.
        Congest Heart Fail. 2003; 9: 287-292
        • Lopez B.
        • Querejeta R.
        • Gonzalez A.
        • et al.
        Impact of treatment on myocardial lysis oxidase expression and collagen cross-linking in patients with heart failure.
        Hypertension. 2009; 53: 236-242
        • Fallick C.
        • Sobotka P.A.
        • Dunlap M.E.
        Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation.
        Circ Heart Fail. 2011; 4: 669-675
        • Zile M.R.
        • Bennett T.D.
        • St John Sutton M.
        • et al.
        Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures.
        Circulation. 2008 Sep 30; 118: 1433-1441
        • Chaudhry S.I.
        • Wang Y.
        • Concato J.
        • Gill T.M.
        • Krumholz H.M.
        Patterns of weight change preceding hospitalization for heart failure.
        Circulation. 2007; 116: 1549-1554
        • Hoffman J.R.
        • Reynolds S.
        Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema.
        Chest. 1987; 92: 586-593
        • Francis G.S.
        • Siegel R.M.
        • Goldsmith S.R.
        • et al.
        Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure.
        Ann Intern Med. 1985; 103: 1-6
        • Kraus P.A.
        • Lipman J.
        • Becker P.J.
        Acute preload effects of furosemide.
        Chest. 1990; 98: 124-128
        • Marik P.E.
        • Flemmer M.
        Narrative review: the management of acute decompensated heart failure.
        J Intensive Care Med. 2012; 27: 343-353
        • Vital F.M.R.
        • Saconato H.
        • Ladeira M.T.
        • et al.
        Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema.
        in: Cochrane database of systematic reviews. 2008 (Issue 3. Art. No.: CD005351)
        • Bussmann W.
        • Schupp D.
        Effect of sublingual nitroglycerin in emergency treatment of severe pulmonary edema.
        Am J Cardiol. 1978; 41: 931-936
        • Cotter G.
        • Metzkor E.
        • Kaluski E.
        • et al.
        Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.
        Lancet. 1998; 351: 389-393
        • Wu M.Y.
        • Chang N.C.
        • Su C.L.
        • et al.
        Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.
        J Crit Care. 2014; 29: 2-9
        • Alqahtani F.
        • Koulouridis I.
        • Susantitaphong P.
        • et al.
        A meta-analysis of continuous vs intermittent infusion of loop diuretics in hospitalized patients.
        J Crit Care. 2014; 29: 10-17
        • Kahveci A.
        • Tuğlular S.
        Kalp Yetmezliğinde İleri Ultrafiltrasyon Seçeneği.
        Klinik Gelişim. 2011; 24: 63-66
        • Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
        Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
        JAMA. 2002; 287: 1531-1540
        • Costanzo M.R.
        • Guglin M.E.
        • Saltzberg M.T.
        • et al.
        Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.
        J Am Coll Cardiol. 2007; 49: 675-683
        • Bart B.A.
        • Boyle A.
        • Bank AJ
        • et al.
        Ultrafiltration versus usual care for hospitalized patients with heart failure: the relief for acutely fluid-overloaded patients with decompensated congestive heart failure (RAPID-CHF) trial.
        J Am Coll Cardiol. 2005; 46: 2043-2046
        • Barkoudah E.
        • Kodali S.
        • Okoroh J.
        • et al.
        Meta-analysis of ultrafiltration versus diuretics treatment option for overload volume reduction in patients with acute decompensated heart failure.
        Arq Bras Cardiol. 2015; 104: 417-425
        • Ignarro L.J.
        • Lippton H.
        • Edwards J.C.
        • et al.
        Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.
        J Pharmacol Exp Ther. 1981; 218: 739-749
        • De Luca L.
        • Fonarow G.C.
        • Adams Jr., K.F.
        • et al.
        Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy.
        Heart Fail Rev. 2007; 12: 97-104
        • Colussi C.
        • Scopece A.
        • Vitale S.
        • et al.
        P300/CBP associated factor regulates nitroglycerin-dependent arterial relaxation by N(epsilon)-lysine acetylation of contractile proteins.
        Arterioscler Thromb Vasc Biol. 2012; 32: 2435-2443
        • Münzel T.
        • Steven S.
        • Daiber A.
        Organic nitrates: update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction.
        Vascul Pharmacol. 2014; 63: 105-113
        • Vizzardi E.
        • Bonadei I.
        • Rovetta R.
        • D'Aloia A.
        When should we use nitrates in congestive heart failure?.
        Cardiovasc Ther. 2013; 31: 27-31
        • Alzahri M.S.
        • Rohra A.
        • Peacock W.F.
        Nitrates as a treatment of acute heart failure.
        Card Fail Rev. 2016; 2: 51-55
        • Viau D.M.
        • Sala-Mercado J.A.
        • Spranger M.D.
        • et al.
        The pathophysiology of hypertensive acute heart failure.
        Heart. 2015; 101: 1861-1867
        • Mebazaa A.
        • Yilmaz M.B.
        • Levy P.
        • et al.
        Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the heart failure Association of the European Society of cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine.
        Eur J Heart Fail. 2015; 17: 544-558
        • Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
        IV nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
        JAMA. 2002; 287: 1531-1540
        • Cohn J.N.
        • Tam S.W.
        • Anand I.S.
        • et al.
        Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a welltreated black population with heart failure: results from A-HeFT.
        J Card Fail. 2007; 13: 331-339
        • Gogia H.
        • Mehra A.
        • Parikh S.
        • et al.
        Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
        J Am Coll Cardiol. 1995; 26: 1575-1580
        • Packer M.
        • Lee W.H.
        • Kessler P.D.
        • et al.
        Prevention and reversal of nitrate tolerance in patients with congestive heart failure.
        N Engl J Med. 1987; 317: 799-804
        • Ho E.C.
        • Parker J.D.
        • Austin P.C.
        • et al.
        Impact of nitrate use on survival in acute heart failure: a propensity-matched analysis.
        J Am Heart Assoc. 2016; 5
        • Gradman A.H.
        • Vekeman F.
        • Eldar-Lissai A.
        • et al.
        Is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database.
        J Card Fail. 2014; 20: 853-863
        • Alexander P.
        • Alkhawam L.
        • Curry J.
        • et al.
        Lack of evidence for intravenous vasodilators in ED patients with acute heart failure: a systematic review.
        Am J Emerg Med. 2015; 33: 133-141
        • Levy P.
        • Compton S.
        • Welch R.
        • et al.
        Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis.
        Ann Emerg Med. 2007; 50: 144-152
        • Sharon A.
        • Shpirer I.
        • Kaluski E.
        • et al.
        High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema.
        J Am Coll Cardiol. 2000; 36: 832-837
        • Wilson S.S.
        • Kwiatkowski G.M.
        • Millis S.R.
        Use of nitroglycerin by bolus prevents intensive care unit admission in patients with acute hypertensive heart failure.
        Am J Emerg Med. 2017 Jan; 35: 126-131
        • Coons J.C.
        • McGraw M.
        • Murali S.
        Pharmacotherapy for acute heart failure syndrome.
        Am J Health Syst Pharm. 2011; 658: 21-35
        • Vasko J.S.
        • Henney R.P.
        • Oldham H.N.
        Mechanisms of action of morphine in the treatment of experimental pulmonary edema.
        Am J Cardiol. 1966; 18: 876-883
        • Vismara L.A.
        • Leamn D.M.
        • Zelis R.
        The effects of morphine on venous tone in patients with acute pulmonary edema.
        Circulation. 1976; 54: 335-337
        • Lee G.
        • DeMaria A.N.
        • Amsterdam E.A.
        • et al.
        Comparative effects of morphine, meperidine and pentazocine on cardiocirculatory dynamics in patients with acute myocardial infarction.
        Am J Med. 1976; 60: 949-955
        • Greenberg S.
        • McGowan C.
        • Xie J.
        • et al.
        Selective pulmonary and venous smooth muscle relaxation by furosemide: a comparison with morphine.
        J Pharmacol Exp Ther. 1994; 270: 1077-1085
        • Kaye A.D.
        • Hoover J.M.
        • Kaye A.J.
        • et al.
        Morphine, opioids, and the feline pulmonary vascular bed.
        Acta Anaesthesiol Scand. 2008; 52: 931-937
        • Hsu H.O.
        • Hickey R.F.
        • Forbes A.R.
        Morphine decreases peripheral vascular resistance and increases capacitance in man.
        Anesthesiology. 1979; 50: 98-102
        • Heart Failure Society of America
        HFSA 2010 comprehensive heart failure practice guidelines.
        J Card Fail. 2010; 16: e1-194
        • Riggs T.R.
        • Yano Y.
        • Vargish T.
        Morphine depression of myocardial function.
        Circ Shock. 1986; 19: 31-38
        • Radke J.B.
        • Owen K.P.
        • Sutter M.E.
        • et al.
        The effects of opioids on the lung.
        Clin Rev Allergy Immunol. 2014; 46: 54-64
        • Pattinson K.T.
        Opioids and the control of respiration.
        Br J Anaesth. 2008; 100: 747-758
        • Chambers J.A.
        • Baggoley C.J.
        Pulmonary oedema—prehospital treatment. Caution with morphine dosage.
        Med J Aust. 1992; 157: 326-328
        • Beltrame J.F.
        • Zeitz C.J.
        • Unger S.A.
        • Brennan R.J.
        • Hunt A.
        • Moran J.L.
        • et al.
        Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema.
        J Card Fail. 1998; 4: 271-279
        • Sacchetti A.
        • Ramoska E.
        • Moakes M.E.
        • et al.
        Effect of ED management on ICU use in acute pulmonary edema.
        Am J Emerg Med. 1999; 17: 571-574
        • Fiutowski M.
        • Waszyrowski T.
        • Krzeminska-Pakula M.
        • et al.
        Clinical presentation and pharmacological therapy in patients with cardiogenic pulmonary oedema.
        Kardiol Pol. 2004; 61 ([discussion 70]): 561-569
        • Sosnowski M.A.
        Review article: lack of effect of opiates in the treatment of acute cardiogenic pulmonary oedema.
        Emerg Med Australas. 2008; 20: 384-390
        • Peacock W.F.
        • Hollander J.E.
        • Diercks D.B.
        • et al.
        Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis.
        Emerg Med J. 2008; 25: 205-209
        • Iakobishvili Z.
        • Cohen E.
        • Garty M.
        • et al.
        Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes.
        Acute Card Care. 2011; 13: 76-80
        • Miró Ò.
        • Gil V.
        • Martín-Sánchez F.J.
        • et al.
        Morphine use in the ED and outcomes of patients with acute heart failure: a propensity score-matching analysis based on the EAHFE registry.
        Chest. 2017 Oct; 152: 821-832
        • Ellingsrud C.
        • Agewall S.
        Morphine in the treatment of acute pulmonary oedema — why?.
        Int J Cardiol. 2016; 202: 870-873
        • Reynolds H.R.
        • Hochman J.S.
        Cardiogenic shock: current concepts and improving outcomes.
        Circulation. 2008; 117: 686-697
        • Amsterdam E.A.
        • Wenger N.K.
        • Brindis R.G.
        • et al.
        For the ACC, AHA task force on practice guidelines, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines.
        J Am Coll Cardiol. 2014 Dec 23; 64: e139-e228
        • Kunadian V.
        • Qiu W.
        • Ludman P.
        • et al.
        For the National Institute for cardiovascular outcomes research. Outcomes in patients with cardiogenic shock following percutaneous coronary intervention in the contemporary era: an analysis from the BCIS database (British cardiovascular intervention society).
        JACC Cardiovasc Interv. 2014 Dec; 7: 1374-1385
        • Hasdai D.
        • Califf R.M.
        • Thompson T.D.
        • et al.
        Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction.
        J Am Coll Cardiol. 2000 Jan; 35: 136-143
        • Jeger R.V.
        • Lowe A.M.
        • Buller C.E.
        • et al.
        Hemodynamic parameters are prognostically important in cardiogenic shock but similar following early revascularization or initial medical stabilization: a report from the SHOCK trial.
        Chest. 2007 Dec; 132: 1794-1803
        • Alonso D.R.
        • Scheidt S.
        • Post M.
        • Killip T.
        Pathophysiology of cardiogenic shock. Quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations.
        Circulation. 1973 Sep; 48: 588-596
        • Ural Dilek
        • Çavuşoğlu Yüksel
        • Eren Mehmet
        Diagnosis and management of acute heart failure.
        Anatol J Cardiol. 2015; 15: 860-889
        • Francis G.S.
        • Bartos J.A.
        • Adatya S.
        J Am Coll Cardiol. 2014; 63: 2069-2078
        • Elkayam U.
        • Ng T.
        • Hatamizadeh P.
        Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action.
        Circulation. 2008; 117: 200-205
        • Goldberg L.L.
        Cardiovascular and renal actions of dopamine: potential clinical applications.
        Pharmacol Rev. 1972; 24: 1-29
        • Rui Q.
        • Jiang Y.
        • Chen M.
        • et al.
        Dopamine versus norepinephrine in the treatment of cardiogenic shock: a PRISMA-compliant meta-analysis.
        Medicine. 2017; 96e8402
        • Nativi-Nicolau J.
        • Selzman C.H.
        • Fang J.C.
        • et al.
        Pharmacologic therapies for acute cardiogenic shock.
        Curr Opin Cardiol. 2014; 29: 250-257
        • Hollenberg S.M.
        Vasoactive drugs in circulatory shock.
        Am J Respir Crit Care Med. 2011; 183: 847-855
        • Bueno H.
        Acute heart failure in Spain: certainties and uncertainties.
        Emergencias. 2015; 27: 7-9
        • Llorens P.
        • manito Lorite N.
        • manzano Espinosa L.
        • et al.
        Consensus for improving the care of patients with acute heart failure.
        Emergencias. 2015; 27: 245-266
        • Storrow A.B.
        • Collins S.P.
        • Lyons M.S.
        • et al.
        Emergency department observation of heart failure: preliminary analysis of safety and cost.
        Congest Heart Fail. 2005; 11: 68-72
        • Schrager J.
        • Wheatley M.
        • Georgiopoulou V.
        • et al.
        Favorable bed utilization and readmission rates for emergency department observation unit heart failure patients.
        Acad Emerg Med. 2013; 20: 554-561
        • Storrow A.B.
        • Jenkins C.A.
        • Self W.H.
        • et al.
        The burden of acute heart failure on US emergency departments.
        JACC Heart Fail. 2014; 2: 269-277
        • Ezekowitz J.A.
        • Bakal J.A.
        • Kaul P.
        • et al.
        Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failure.
        Eur J Heart Fail. 2008; 10: 308-314
        • Lee D.S.
        • Schull M.J.
        • Alter D.A.
        • et al.
        Early deaths in patients with heart failure discharged from the emergency department: a population-based analysis.
        Circ Heart Fail. 2010; 3: 228-235
        • Brar S.
        • McAlister F.A.
        • Youngson E.
        • Rowe B.H.
        Do outcomes for patients with heart failure vary by emergency department volume?.
        Circ Heart Fail. 2013; 6: 1147-1154
        • Llorens P.
        • Escoda R.
        • Miró O.
        • et al.
        Characteristics and clinical course of patients with acute heart failure and the therapeutic measures applied in Spanish emergency departments: based on the EAHFE registry (epidemiology of acute heart failure in emergency departments).
        Emergencias. 2015; 27: 11-22
        • Blecker S.
        • Ladapo J.A.
        • Doran K.M.
        • et al.
        Emergency department visits for heart failure and subsequent hospitalization or observation unit admission.
        Am Heart J. 2014; 168: 901
        • Miró O.
        • Gil V.
        • Herrero P.
        • et al.
        ICA-SEMES research group. Multicentric investigation of survival after Spanish emergency department discharge for acute heart failure.
        Eur J Emerg Med. 2012; 19: 153-160
        • Rame J.E.
        • Sheffield M.A.
        • Dries D.L.
        • et al.
        Outcomes after emergency department discharge with primary diagnosis of heart failure.
        Am Heart J. 2001; 142: 714-719
        • Vashi A.A.
        • Fox J.P.
        • Carr B.G.
        • et al.
        Use of hospital-based acute care among patients recently discharged from the hospital.
        JAMA. 2013; 309: 364-371
        • Parenica J.
        • Spinar J.
        • Vitovec J.
        • et al.
        Longterm survival following acute heart failure: the acute heart failure database main registry (AHEAD main).
        Eur J Intern Med. 2013; 24: 151-160
        • Siirilä-Waris K.
        • Lassus J.
        • Melin J.
        • et al.
        FINN-AKVA study group. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure.
        Eur Heart J. 2006; 27: 3011-3017
        • Lassus J.
        • Gayat E.
        • Mueller C.
        • et al.
        Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the multinational observational cohort on acute heart failure (MOCA) study.
        Int J Cardiol. 2013; 168: 2186-2194
        • Fonarow G.C.
        • Adams Jr., K.F.
        • Abraham W.T.
        • et al.
        Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.
        JAMA. 2005; 293: 572-580
        • Miró Ò.
        • Levy P.D.
        • Möckel M.
        • et al.
        Disposition of emergency department patients diagnosed with acute heart failure: an international emergency medicine perspective.
        Eur J Emerg Med. 2017 Feb; 24: 2-12
        • Lee D.S.
        • Austin P.C.
        • Rouleau J.L.
        • et al.
        Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.
        JAMA. 2003; 290: 2581-2587
        • Martín-Sánchez F.J.
        • Gil V.
        • Llorens P.
        • et al.
        Acute heart failure working Group of the Spanish Society of emergency medicine investigation group. Barthel index-enhanced feedback for effective cardiac treatment (BI-EFFECT) study: contribution of the Barthel index to the heart failure risk scoring system model in elderly adults with acute heart failure in the emergency department.
        J Am Geriatr Soc. 2012; 60: 493-498
        • Salah K.
        • Kok W.E.
        • Eurlings L.W.
        • et al.
        A novel discharge risk model for patients hospitalized for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European collaboration on acute decompensated heart failure: ÉLAN-HF score.
        Heart. 2014; 100: 115-125
        • Chin M.H.
        • Goldman L.
        • Chin M.H.
        • et al.
        Correlates of major complications or death in patients admitted to the hospital with congestive heart failure.
        Arch Intern Med. 1996; 156: 1814-1820
        • Auble T.E.
        • Hsieh M.
        • Gardner W.
        • et al.
        A prediction rule to identify low-risk patients with heart failure.
        Acad Emerg Med. 2005; 12: 514-521
        • Rohde L.E.
        • Goldraich L.
        • Polanczyk C.A.
        • et al.
        A simple clinically based predictive rule for heart failure in-hospital mortality.
        J Card Fail. 2006; 12: 587-593
        • Peterson P.N.
        • Rumsfeld J.S.
        • Liang L.
        • et al.
        A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program.
        Circ Cardiovasc Qual Outcomes. 2010; 3: 25-32
        • Stiell I.G.
        • Clement C.M.
        • Brison R.J.
        • et al.
        A risk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events.
        Acad Emerg Med. 2013 Jan; 20: 17-26
        • Stiell I.G.
        • Perry J.J.
        • Clement C.M.
        • et al.
        Prospective and explicit clinical validation of the Ottawa heart failure risk scale, with and without use of quantitative NT-proBNP.
        Acad Emerg Med. 2017 Mar; 24: 316-327
        • Lee D.S.
        • Stitt A.
        • Austin P.C.
        • et al.
        Prediction of heart failure mortality in emergent care: a cohort study.
        Ann Intern Med. 2012 Jun 5; 156 ([W-261, W-262]): 767-775
        • Metra M.
        • Nodari S.
        • Parrinello G.
        • et al.
        Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance.
        Eur J Heart Fail. 2008; 10: 188-195
        • Gottlieb S.S.
        • Abraham W.
        • Butler J.
        • et al.
        The prognostic importance of different definitions of worsening renal function in congestive heart failure.
        J Card Fail. 2002; 8: 136-141
        • Schrier R.W.
        Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?.
        J Am Coll Cardiol. 2006; 47: 1-8
        • Klein L.
        • Massie B.M.
        • Leimberger J.D.
        • et al.
        Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the outcomes of a prospective trial of intravenous Milrinone for exacerbations of chronic heart failure (OPTIME-CHF).
        Circ Heart Fail. 2008; 1: 25-33
        • Smith G.L.
        • Lichtman J.H.
        • Bracken M.B.
        • et al.
        Renal impairment and outcomes in heart failure: systematic review and meta-analysis.
        J Am Coll Cardiol. 2006; 47: 1987-1996
        • Hillege H.L.
        • Nitsch D.
        • Pfeffer M.A.
        • et al.
        Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
        Circulation. 2006; 113: 671-678

      CHORUS Manuscript

      View Open Manuscript